Eletriptan
Alternative Names: Relert; Relpax; UK 116044Latest Information Update: 05 Nov 2023
At a glance
- Originator Pfizer
- Class Antimigraines; Pyrrolidines; Small molecules; Tryptamines
- Mechanism of Action Serotonin 1D receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Menstrual migraine; Migraine
Most Recent Events
- 11 Apr 2003 Data presented at the 55th Annual Meeting of the American Academy of Neurology (AAN-2003) have been added to the adverse events , pharmacokinetics section , and Nausea and migraine therapeutic trials section
- 03 Mar 2003 Launched for Migraine in USA (PO)
- 16 Jan 2003 Launched for Migraine in France (PO)